Inventor · disambiguated record
Daniel H.S. Lee
Also filed as: LEE DANIEL H · LEE DANIEL H S
16 granted patents·10 pending applications·221 citations·filing 1999–2015
94Inventor score
Top patents by PatentIndex Score
26 records- 0193US8153580B2Nogo receptor binding proteinMI SHA·Filed 2010·Granted Apr 10, 2012·17 cites·16 claims
- 0293US7465705B2Nogo receptor antagonistsUNIV YALE·Filed 2005·Granted Dec 16, 2008·37 cites·12 claims
- 0388US7319107B21,2,4-thiadiazolium derivatives as melanocortin receptor modulatorsJOHNSON & JOHNSON CONSUMER·Filed 2002·Granted Jan 15, 2008·25 cites·25 claims
- 0487US8669345B2Nogo receptor antagonistsLEE DANIEL H S·Filed 2007·Granted Mar 11, 2014·16 cites·3 claims
- 0587US7375123B21,2,4-thiadiazole derivatives as melanocortin receptor modulatorsORTHO MCNEIL PHARM INC·Filed 2006·Granted May 20, 2008·10 cites·9 claims
- 0687US7049331B21,2,4-thiadiazole derivatives as melanocortin receptor modulatorsORTHO MCNEIL PHARM INC·Filed 2002·Granted May 23, 2006·26 cites·19 claims
- 0786US8765662B2NOGO receptor binding proteinMI SHA·Filed 2012·Granted Jul 1, 2014·6 cites·16 claims
- 0885US7785829B2Nogo receptor binding proteinBIOGEN IDEC INC·Filed 2004·Granted Aug 31, 2010·15 cites·29 claims
- 0985US7786311B21,2,4-thiadiazolium derivatives as melanocortin receptor modulatorsORTHO MCNEIL PHARM INC·Filed 2008·Granted Aug 31, 2010·6 cites·3 claims
- 1081US8932821B2NOGO receptor binding proteinBIOGEN IDEC INC·Filed 2013·Granted Jan 13, 2015·3 cites·4 claims
- 1180US7018797B2Method for treating neurodegenerative disordersORTHO MCNEIL PHARM INC·Filed 2002·Granted Mar 28, 2006·11 cites·8 claims
- 1278US6441049B2Method of treating neurodegenerative disorders via inhibition of amyloid beta peptide bindingORTHO MCNEIL PHARM INC·Filed 1999·Granted Aug 27, 2002·37 cites·14 claims
- 1376US9228015B2Nogo receptor antagonists and methods of increasing neurite outgrowthBIOGEN IDEC INC·Filed 2014·Granted Jan 5, 2016·2 cites·5 claims
- 1476US8030456B2Nogo receptor antagonistsUNIV YALE·Filed 2008·Granted Oct 4, 2011·2 cites·2 claims
- 1573US8501791B21,2,4-thiadiazolium derivatives as melanocortin receptor modulatorsEISINGER MAGDALENA·Filed 2010·Granted Aug 6, 2013·2 cites·7 claims
- 1671US6407136B11,4-dithiin and 1,4-dithiepin-1,1,4,4, tetroxide derivatives useful as antagonists of the human galanin receptorORTHO MCNEIL PHARM INC·Filed 2000·Granted Jun 18, 2002·6 cites·25 claims
- 1764US2015177240A1Nogo Receptor Binding ProteinBIOGEN IDEC INC·Filed 2014·Application pending·0 cites
- 1856US2006030604A1Novel 1,2,4-thiadiazolium derivatives as melanocortin receptor modulatorsELSINGER MAGDALENA·Filed 2005·Application pending·0 cites
- 1953US2012058125A1Methods relating to peripheral administration of nogo receptor polypeptidesSTRITTMATTER STEPHEN M·Filed 2007·Application pending·0 cites
- 2048US2008274112A1Nogo Receptor AntagonistsLEE DANIEL H S·Filed 2004·Application pending·0 cites
- 2148US2016159878A1NOGO Receptor AntagonistsBIOGEN MA INC·Filed 2015·Application pending·0 cites
- 2246US2012219567A1Methods Relating to Peripheral Administration of Nogo Receptor PolypeptidesSTRITTMATTER STEPHEN M·Filed 2012·Application pending·0 cites
- 2346US2007065429A1Nogo-receptor antagonists for the treatment of conditions involving amyloid plaquesUNIV YALE·Filed 2004·Application pending·0 cites
- 2445US2009062199A1Nogo Receptor Polypeptides and Polypeptide Fragments and Uses ThereofBIOGEN IDEC INC·Filed 2006·Application pending·0 cites
- 2540US2003092613A1Alpha7 nicotinic receptor peptides as ligands for beta amyloid peptidesFiled 2001·Application pending·0 cites
- 2639US2009053229A1Methods of Treating Conditions Involving Neuronal DegenerationLEE DANIEL H S·Filed 2006·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →